Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Thymus based tolerance to stem cell therapies

  • Post author:
  • Post published:November 6, 2025
  • Post category:

This proposal focuses on the role of the immune system in transplantation of derivatives of human pluripotent stem cells (hPSCs). A critical roadblock to successful cell replacement therapies, no matter…

Continue ReadingThymus based tolerance to stem cell therapies

Purified allogeneic hematopoietic stem cells as a platform for tolerance induction

  • Post author:
  • Post published:November 6, 2025
  • Post category:

Blood and immune cells originate and mature in the bone marrow. Bone marrow cells are mixtures of blood cells at different stages of development, and include rare populations of blood-forming…

Continue ReadingPurified allogeneic hematopoietic stem cells as a platform for tolerance induction

Stem cell tolerance through the use of engineered antigen-specific regulatory T cells

  • Post author:
  • Post published:November 6, 2025
  • Post category:

Type 1 Diabetes (T1D) occurs as a consequence of uncontrolled immune activation, culminating in the destruction of insulin-producing beta-cells. Efforts to prevent or reverse diabetes have been limited by the…

Continue ReadingStem cell tolerance through the use of engineered antigen-specific regulatory T cells

Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells

  • Post author:
  • Post published:November 6, 2025
  • Post category:

The thymus is an organ that plays a key role in controlling immune responses and immune tolerance. The thymus promotes immune tolerance by deleting and removing self-reactive T cells from…

Continue ReadingStem cell differentiation to thymic epithelium for inducing tolerance to stem cells

Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses

  • Post author:
  • Post published:November 6, 2025
  • Post category:

Embryonic stem cells open up exciting new prospects for medicine, because they can differentiate into any tissue in the body. Therefore, they have the potential to be used to repair…

Continue ReadingSafe, efficient creation of human induced pluripotent stem cells without the use of retroviruses

Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells

  • Post author:
  • Post published:November 6, 2025
  • Post category:

The capacity of human embryonic stem cells (hESCs) to perpetuate themselves indefinitely in culture and to differentiate to all cell types of the body has lead to numerous studies that…

Continue ReadingProspective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells

Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease

  • Post author:
  • Post published:November 6, 2025
  • Post category:

AIDS is a disease that currently has no cure. It arises when the human immunodeficiency virus (HIV) infects certain types of blood cells. These cells would normally be used to…

Continue ReadingHuman Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease

Human stem cell derived oligodendrocytes for treatment of stroke and MS

  • Post author:
  • Post published:November 6, 2025
  • Post category:

Strokes that affect the nerves cells, i.e., “gray matter”, consistently receive the most attention. However, the kind of strokes that affecting the “wiring” of the brain, i.e., “white matter”, cause…

Continue ReadingHuman stem cell derived oligodendrocytes for treatment of stroke and MS

Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination

  • Post author:
  • Post published:November 6, 2025
  • Post category:

Multiple sclerosis (MS) is the most common neurologic disease affecting young adults under the age of 40 with the majority of MS patients diagnosed in the second or third decade…

Continue ReadingHuman Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination

Embryonic stem cell-derived thymic epithelial cells

  • Post author:
  • Post published:November 6, 2025
  • Post category:

The function of the immune system throughout life is essential for protection from infections and cancer. T lymphocytes are white blood cells that choreograph the multiple responses that the body…

Continue ReadingEmbryonic stem cell-derived thymic epithelial cells
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us